Nivolumab vs Rabeprazole
Nivolumab vs Rabeprazole: Overview
This comparison examines the pharmacological differences between Nivolumab and Rabeprazole.
Mechanism of Action
Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.
Rabeprazole: Proton pump inhibitor irreversibly inhibiting gastric H+/K+-ATPase with faster onset than omeprazole.
Pharmacokinetics
Half-life: Nivolumab — 27 days; Rabeprazole — 1-2 hours.
Chemical Properties
Molecular Formula: Rabeprazole — C18H21N3O3S.
Molecular Weight: Rabeprazole — 359.4440 g/mol.
Type: Nivolumab — Antibody; Rabeprazole — Small molecule.